Name: UMIN ID:
Unique ID issued by UMIN | UMIN000022221 |
---|---|
Receipt number | R000025592 |
Scientific Title | Feasibility study for 2nd line combination chemotherapy of Nab-paclitaxel with Ramucirumab for inoperable advanced recurrent gastric cancer. |
Date of disclosure of the study information | 2016/07/01 |
Last modified on | 2019/05/09 12:08:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/05/06 14:25:02 | ||
2 | Update | 2017/11/06 11:57:03 | Recruitment status |
|
3 | Update | 2019/05/09 12:08:34 | Recruitment status Date of IRB Last follow-up date |